Crystal and molecular structure of an (S)-(+)-enantiomer of modafinil, a novel wake-promoting agent. 2004

Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
Department of Physical Chemistry, Osaka University of Pharmaceutical Sciences, Osaka, Japan. in@gly.oups.ac.jp

The (+)-enantiomer of modafinil [(RS)-2-(diphenylmethylsulfinyl)acetamide], a novel wake-promoting agent, was clarified to be S-configuration by X-ray crystal structure analysis. The crystal consists of two crystallographically independent conformers that are different at the torsion angles around the sulfinylacetamide moiety, and this results from the molecular packing requirement to form a two-dimensional hydrogen-bonding network via neighboring amide groups in the crystal. The crystal structure is characterized by the formation of alternative hydrophobic and hydrophilic layers, which are formed among the symmetry-translated assemblies of diphenylmethyl and sulfinylacetamide moieties, respectively. The spatial orientation between the diphenyl and amide groups is believed to be important for the activity of modafinil.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D000077408 Modafinil A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS. 2-(Benzhydrylsulfinyl)acetamide,2-Benzhydrylsulfinylacetamide,2-((Diphenylmethyl)sulfinyl)acetamide,2-((R)-(Diphenylmethyl)sulfinyl)acetamide,Alertec,Armodafinil,Benzhydrylsulfinylacetamide,CRL 40476,CRL-40476,Modiodal,Nuvigil,Provigil,R-Modafinil,Sparlon,2 Benzhydrylsulfinylacetamide,R Modafinil
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D001559 Benzhydryl Compounds Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed. Diphenylmethyl Compounds,Compounds, Benzhydryl,Compounds, Diphenylmethyl
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
November 2006, Pharmacology, biochemistry, and behavior,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
October 2021, Pharmacology research & perspectives,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
December 1998, Neuroscience,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
May 2022, Nature communications,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
June 2010, Pharmacology, biochemistry, and behavior,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
October 1972, Nature,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
January 2005, Neuroscience,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
August 2012, European journal of medicinal chemistry,
Yasuko In, and Koji Tomoo, and Toshimasa Ishida, and Yasuhiko Sakamoto
March 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!